New Schedule M rules: Most drug companies not yet ready for upgrade
With the revised Schedule M deadline approaching, only a fraction of small and medium pharmaceutical companies have submitted facility upgrade plans. The health ministry, concerned about the slow response, has urged state health secretaries to engage with local drugmakers. This aims to ensure broader compliance with the updated quality standards outlined in Schedule M of the Drugs and Cosmetics Act.
Tired of too many ads?
Remove Ads
Only a small number of pharmaceutical companies have submitted plans for upgradation of facilities even as a revised deadline for implementation of revised Schedule M ends on Monday. Health ministry officials said out of about 10,000 medium and small manufacturing enterprises, just about 100 have submitted applications.Health secretary Punya Salila Srivastava has now written to state health secretaries, asking them to issue necessary directions to state drug regulators to discuss the matter with drugmakers in their own areas.Schedule M of the Drugs and Cosmetics Act outlines quality standards for pharmaceutical products.This February, the ministry issued a notification extending the deadline for implementing revised Schedule M, whereby manufacturers with revenues of less than ₹250 crore were required to submit applications to the Central License Approving Authority within three months, along with their upgradation plans "However, as per the data available, very few firms have submitted their application requesting extension of timelines for implementation of revised Schedule M," said the health secretary in her letter to states.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
2 hours ago
- Hindustan Times
Inspection at ESIC hospital, medical stores in Noida, 9 medicines sampled
In a bid to ensure that medicines being sold in the district adhere to prescribed safety and quality standards, the food safety and drug administration (FSDA) conducted a surprise inspection at ESIC hospital in Section 24 and multiple medical facilities in Noida, said officials on Friday. Officials said all collected samples have been sent for testing. (Shutterstock) The inspections were carried out under the directives of the commissioner of Food Safety and Drug Administration, Uttar Pradesh, and district magistrate, Gautam Budh Nagar Manish Kumar Verma. During inspections, nine samples of several medicines were collected and sent for laboratory testing. Officials have stated that further action will be initiated based on the results of these tests. 'Five samples were collected from the ESIC hospital, and two each from a Jan Aushadhi Kendra and another from a medical store, both located in Sector 22. All collected samples have been sent for testing at the designated drug testing laboratory and further action will be initiated based on the results', said drug inspector, Jai Singh. Speaking about the ongoing efforts, the official emphasised that the campaign to monitor and ensure drug quality across the district is part of a wider initiative under the Food Safety and Drug Administration. 'The drive is aimed at making sure that all kinds of medicines being sold at medical stores across the district meet the prescribed standards and are safe for public use,' said Singh. He further added that similar inspections will continue in the coming days to prevent the sale of substandard or spurious drugs. Random checks will be intensified across private pharmacies, government-linked centers, and hospitals to uphold the integrity of drug quality in the district. Officials assured that if any irregularities are found in the samples upon lab analysis, strict regulatory action, including penalties and suspension of licenses, will be pursued as per the Drugs and Cosmetics Act.
Hindustan Times
13 hours ago
- Hindustan Times
Nagaland pharmacy association appeals to state govt for policy review claiming pharmacist shortage
Kohima, The All Nagaland Pharmacy Association has urged the state government to reconsider the strict enforcement of rules mandating registered pharmacists in all pharmacies, warning that the move could lead to widespread closures and disrupt healthcare access across Nagaland. At a press conference in Kohima on Friday, ANPA president Zhapuvilie Yashü and general secretary Limayanger Jamir said that although they respect and are willing to comply with the Drugs and Cosmetics Act, 1940, Drugs and Cosmetics Rules, 1945, and Pharmacy Act, 1948, the shortage of qualified pharmacists makes full implementation currently unfeasible. Quoting official data that there are 1,157 licensed pharmacies in Nagaland, Jamir claimed the state has only 278 registered pharmacists, of which, 252 are employed in government facilities, leaving just 26 for private pharmacies. Several districts, including Shamator and Meluri, have no registered pharmacists at all. Phek district, with 34 pharmacies, has only two while even in Kohima, some localities could be left without a single pharmacy if the rule is strictly enforced, he said. "This ratio is grossly disproportionate. Enforcing the rule without practical alternatives will throw the public health system into disarray," Jamir warned. ANPA said the licensing process has long been regulated by the Health & Family Welfare department, with pharmacies regularly paying fees. However, in late 2021, the department began enforcing stricter requirements for pharmacist appointments, it said. Yashu said while some private pharmacies have appointed pharmacists, most cannot do so due to the acute shortage. To address the issue collectively, pharmacy unions were formed in every district and unified under ANPA on March 13 this year, he said. ANPA said that despite repeated appeals to the Principal Director, Health Commissioner, and Health Minister, the association said their requests for a phased implementation or temporary relaxation have not been addressed while a representation to the chief minister is still pending. "If enforced fully, even key areas in Kohima and several districts will be left without pharmacy services," ANPA said. Pointing out that Nagaland is currently the only state in India without a pharmacy institute, ANPA said that even in other states, full enforcement of such policies has been hindered by manpower shortages. They questioned the government's expectations, noting that many government health centres rely on nurses trained for only three months to dispense medicines. "If the government can authorise nurses due to shortages, similar temporary measures should be extended to pharmacies until infrastructure is improved," ANPA argued. While the Drugs Control Administration had renewed licenses until 2028, pharmacies have recently begun receiving show cause notices and cancellation orders from May onwards, they said. ANPA clarified it is not opposing the policy but asking for a practical, state-specific approach that protects public health without disrupting essential services. "Until we have sufficient manpower and our own pharmacy institutions, we request the department to allow pharmacies to continue operating," the association appealed. They assured that if granted a reasonable extension, efforts to appoint registered pharmacists would continue. Meanwhile, Tiatoshi Amer, Controlling & Licensing Authority under the Health & Family Welfare Department, told PTI that the department acted only after repeated notices went unheeded. "We issued public notices and also verbally informed licensees to appoint pharmacists for the welfare of the public," he said. Amer added that the department will not consider an extension as enough time had already been provided, emphasising that public health remains the department's top priority. The officer also asserted that, as per data provided by the department's Pharmacy Cell, there are more than 300 registered unemployed pharmacists in the state, while for the government health units, the vacant posts are being requisitioned annually through the Nagaland Public Service Commission for recruitment.
Time of India
2 days ago
- Time of India
Centre extends deadline for revised Schedule M implementation for small, medium pharmas
Mysuru: The Union govt has extended the deadline for implementing the revised Schedule M–Good Manufacturing Practices (GMP)–for small and medium pharmaceutical enterprises (SMEs) with an annual turnover of Rs 250 crore or less, until the end of this year, said Khalid Ahmed Khan, deputy drug controller and president of the Indian Pharmaceutical Association (IPA), Karnataka state branch. He was speaking at the inauguration of a national conference on 'Enhancing Pharmaceutical Quality Assurance through Good Manufacturing Practices (GMP)' and a special session on the Revamped Pharmaceutical Technology Upgradation Assistance Scheme. The event was organised by the PHD Chamber of Commerce and Industry (PHDCCI) health committee in association with the department of pharmaceuticals, Union ministry of chemicals and fertilizers, JSS Academy of Higher Education and Research (JSS AHER) and the IPA Mysuru branch, at the JSS College of Pharmacy on Wednesday. Khan noted that due to the financial burden involved in implementing the revised quality framework, MSME firms were granted time until Dec 2025 to comply. "Firms with turnover above Rs 250 crore, as well as all newly established plants, are required to adopt the revised Schedule M immediately. These guidelines are aligned with WHO and international standards and emphasise total quality management and robust pharmaceutical systems," he added. Khan stressed the importance of leadership and a quality-driven mindset in the pharmaceutical sector. "Even if you're not in a leadership position, you can influence those who are. Without quality, neither the industry nor its workforce can sustain," he said. Dr H Basavana Gowdappa, VC, JSS AHER, commended the department of pharmaceuticals for launching the RPTUAS and urged the industry to treat GMP not as a regulation but a fundamental responsibility. Amaresh Tumbagi, former drug controller of Karnataka, outlined the inspection mechanisms under the revised Schedule M and how regulatory processes have evolved. Dr Pramod Kumar TM, principal, JSS College of Pharmacy, provided insights into current industry regulations and compliance requirements. Jatin Nagpal, joint secretary, PHDCCI, Dharmendra Kumar Yadav, under secretary, department of pharmaceuticals, Yashwant Shinde, manager, SIDBI and Dr Savitha RS, secretary, IPA Mysuru local branch were also present.
